{"transactions":[{"id":724140,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-29T20:31:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":2417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2417,"derivative":{"underlying":"Common Stock","underlying_shares":2417},"source":{"system":"sec-edgar","filing":"0001458643-26-000004","document":"wk-form4_1782765084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000145864326000004/wk-form4_1782765084.xml","form_type":"4"}},{"id":724139,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:31:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":3837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3837,"derivative":{"exercise_price":64.34,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":3837},"source":{"system":"sec-edgar","filing":"0001458643-26-000004","document":"wk-form4_1782765084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000145864326000004/wk-form4_1782765084.xml","form_type":"4"}},{"id":736351,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-16T20:06:13.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":2954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2954},"source":{"system":"sec-edgar","filing":"0001458643-26-000002","document":"wk-form4_1781640370.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000145864326000002/wk-form4_1781640370.xml","form_type":"4"}},{"id":736350,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:06:13.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":2954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":11654,"source":{"system":"sec-edgar","filing":"0001458643-26-000002","document":"wk-form4_1781640370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000145864326000002/wk-form4_1781640370.xml","form_type":"4"}},{"id":1109708,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T00:16:55.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":20568,"derivative":{"exercise_price":13.5,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":20568},"source":{"system":"sec-edgar","filing":"0002065881-25-000022","document":"wk-form4_1750119408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000206588125000022/wk-form4_1750119408.xml","form_type":"4"}},{"id":1109707,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:16:55.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on December 11, 2024, maintained by the Company."}],"balance_after":867826,"source":{"system":"sec-edgar","filing":"0002065881-25-000022","document":"wk-form4_1750119408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000206588125000022/wk-form4_1750119408.xml","form_type":"4"}},{"id":1109898,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:05:31.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-25-000094","document":"wk-form4_1750104325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000094/wk-form4_1750104325.xml","form_type":"4"}},{"id":1109897,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:05:31.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":2954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2954,"derivative":{"underlying":"Common Stock","underlying_shares":2954},"source":{"system":"sec-edgar","filing":"0001819790-25-000094","document":"wk-form4_1750104325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000094/wk-form4_1750104325.xml","form_type":"4"}},{"id":1109896,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T20:05:31.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":4540,"derivative":{"exercise_price":40.95,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":4540},"source":{"system":"sec-edgar","filing":"0001819790-25-000094","document":"wk-form4_1750104325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000094/wk-form4_1750104325.xml","form_type":"4"}},{"id":1109895,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:05:31.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":8700,"source":{"system":"sec-edgar","filing":"0001819790-25-000094","document":"wk-form4_1750104325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000094/wk-form4_1750104325.xml","form_type":"4"}},{"id":1469598,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:22:23.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000098","document":"wk-form4_1719354137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000098/wk-form4_1719354137.xml","form_type":"4"}},{"id":1469597,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T22:22:23.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":5350,"source":{"system":"sec-edgar","filing":"0001819790-24-000098","document":"wk-form4_1719354137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000098/wk-form4_1719354137.xml","form_type":"4"}},{"id":1475122,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:51:22.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":27052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":27052,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":27052},"source":{"system":"sec-edgar","filing":"0001787306-24-000099","document":"wk-form4_1718743875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000178730624000099/wk-form4_1718743875.xml","form_type":"4"}},{"id":1475121,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:51:22.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.  The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":860217,"source":{"system":"sec-edgar","filing":"0001787306-24-000099","document":"wk-form4_1718743875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000178730624000099/wk-form4_1718743875.xml","form_type":"4"}},{"id":1479232,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-14T21:44:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000083","document":"wk-form4_1718401434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000083/wk-form4_1718401434.xml","form_type":"4"}},{"id":1479231,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:44:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":33.14,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-24-000083","document":"wk-form4_1718401434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000083/wk-form4_1718401434.xml","form_type":"4"}},{"id":1844322,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-26T21:58:47.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-23-000060","document":"wk-form4_1687816717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000060/wk-form4_1687816717.xml","form_type":"4"}},{"id":1844321,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T21:58:47.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":17.99,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-23-000060","document":"wk-form4_1687816717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000060/wk-form4_1687816717.xml","form_type":"4"}},{"id":1847974,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T22:25:42.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001819790-23-000045","document":"wk-form4_1687386330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000045/wk-form4_1687386330.xml","form_type":"4"}},{"id":1847973,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:25:42.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001819790-23-000045","document":"wk-form4_1687386330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000045/wk-form4_1687386330.xml","form_type":"4"}},{"id":1869590,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T23:13:43.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":12220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023."}],"balance_after":12220,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":12220},"source":{"system":"sec-edgar","filing":"0001787306-23-000060","document":"wk-form4_1685747612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000178730623000060/wk-form4_1685747612.xml","form_type":"4"}},{"id":1869589,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:13:43.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":850078,"source":{"system":"sec-edgar","filing":"0001787306-23-000060","document":"wk-form4_1685747612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000178730623000060/wk-form4_1685747612.xml","form_type":"4"}},{"id":2217437,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T16:30:39.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001628280-22-018347","document":"wf-form4_165669302435061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018347/wf-form4_165669302435061.xml","form_type":"4"}},{"id":2217436,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:30:39.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":7000,"derivative":{"exercise_price":12.89,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001628280-22-018347","document":"wf-form4_165669302435061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018347/wf-form4_165669302435061.xml","form_type":"4"}},{"id":2244491,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:57:04.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022."}],"balance_after":11796,"derivative":{"exercise_price":20.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11796},"source":{"system":"sec-edgar","filing":"0001567619-22-012321","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761922012321/doc1.xml","form_type":"4"}},{"id":2244490,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:57:04.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":4312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,312 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":845703,"source":{"system":"sec-edgar","filing":"0001567619-22-012321","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761922012321/doc1.xml","form_type":"4"}},{"id":2653368,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T20:11:20.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":6755,"price":27.5,"value":185762.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":841391,"source":{"system":"sec-edgar","filing":"0001567619-21-012655","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921012655/doc1.xml","form_type":"4"}},{"id":2653367,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T20:11:20.000Z","date":"2021-06-24","kind":"sale","acquired":false,"shares":729,"price":27.5,"value":20047.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":848146,"source":{"system":"sec-edgar","filing":"0001567619-21-012655","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921012655/doc1.xml","form_type":"4"}},{"id":2657045,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T21:47:17.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":2516,"price":27.5,"value":69190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":848875,"source":{"system":"sec-edgar","filing":"0001567619-21-012548","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921012548/doc1.xml","form_type":"4"}},{"id":2664118,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:20:06.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":35.26,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-041702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121041702/doc4.xml","form_type":"4"}},{"id":2664117,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:20:06.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":10000,"derivative":{"exercise_price":35.26,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-041702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121041702/doc4.xml","form_type":"4"}},{"id":2671803,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:34:33.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":13391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of (i) the first anniversary of June 9, 2021 or (ii) the next Annual Meeting following June 9, 2021, subject to Reporting Person's continuous service as a director until such vesting date."}],"balance_after":13391,"derivative":{"exercise_price":27.77,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":13391},"source":{"system":"sec-edgar","filing":"0001567619-21-012024","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921012024/doc1.xml","form_type":"4"}},{"id":2683112,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T20:39:13.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":10000,"price":27.5,"value":275000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":851391,"source":{"system":"sec-edgar","filing":"0001567619-21-011610","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921011610/doc1.xml","form_type":"4"}},{"id":2705384,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T22:43:16.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":1280,"price":28.5277,"value":36515.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $28.50 to $28.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Form 4/A filed by the Reporting Person on 5/12/2021 was filed in error. The original Form 4 filed by the Reporting Person on 04/22/2021 accurately reported the transactions as they occurred. This Form 4/A corrects the aforementioned error by restating the original Form 4 in its entirety."}],"balance_after":861391,"source":{"system":"sec-edgar","filing":"0001567619-21-010739","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921010739/doc1.xml","form_type":"4/A","original_submission_date":"2021-04-22"}},{"id":2705383,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T22:43:16.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":8720,"price":27.9877,"value":244052.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $28.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Form 4/A filed by the Reporting Person on 5/12/2021 was filed in error. The original Form 4 filed by the Reporting Person on 04/22/2021 accurately reported the transactions as they occurred. This Form 4/A corrects the aforementioned error by restating the original Form 4 in its entirety."}],"balance_after":862671,"source":{"system":"sec-edgar","filing":"0001567619-21-010739","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921010739/doc1.xml","form_type":"4/A","original_submission_date":"2021-04-22"}},{"id":2741883,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T00:17:56.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":1280,"price":28.5277,"value":36515.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $28.50 to $28.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":861391,"source":{"system":"sec-edgar","filing":"0001567619-21-008502","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921008502/doc1.xml","form_type":"4"}},{"id":2741882,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T00:17:56.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":8720,"price":27.9877,"value":244052.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $28.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":862671,"source":{"system":"sec-edgar","filing":"0001567619-21-008502","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921008502/doc1.xml","form_type":"4"}},{"id":2773070,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-24T15:33:21.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":4992,"price":31.4314,"value":156905.5488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $31.24 to $31.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":871391,"source":{"system":"sec-edgar","filing":"0001567619-21-006825","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921006825/doc1.xml","form_type":"4"}},{"id":2773069,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-24T15:33:21.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":5008,"price":30.7738,"value":154115.1904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $30.20 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":876383,"source":{"system":"sec-edgar","filing":"0001567619-21-006825","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921006825/doc1.xml","form_type":"4"}},{"id":2835775,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T20:33:06.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":2789,"price":35.9718,"value":100325.3502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $35.80 to $36.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":881391,"source":{"system":"sec-edgar","filing":"0001567619-21-004762","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921004762/doc1.xml","form_type":"4"}},{"id":2835774,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T20:33:06.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":7211,"price":35.344,"value":254865.584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $34.80 to $35.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":884180,"source":{"system":"sec-edgar","filing":"0001567619-21-004762","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921004762/doc1.xml","form_type":"4"}},{"id":2885437,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T00:39:50.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":9949,"price":33.25,"value":330804.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":891391,"source":{"system":"sec-edgar","filing":"0001567619-21-002041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921002041/doc1.xml","form_type":"4"}},{"id":2885436,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T00:39:50.000Z","date":"2021-01-29","kind":"sale","acquired":false,"shares":51,"price":27.5,"value":1402.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":901340,"source":{"system":"sec-edgar","filing":"0001567619-21-002041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761921002041/doc1.xml","form_type":"4"}},{"id":2917756,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-01-06T11:00:39.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":2000,"derivative":{"exercise_price":0.74,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000352998-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000035299821000003/primary_doc.xml","form_type":"4"}},{"id":3232059,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T01:57:20.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable 100% on the earlier of the date of the next annual meeting of the Issuer's stockholders or February 27, 2021."}],"balance_after":24000,"derivative":{"exercise_price":27.61,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001567619-20-005543","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761920005543/doc1.xml","form_type":"4"}},{"id":3291612,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-04T23:26:31.000Z","date":"2020-02-04","kind":"exercise","acquired":false,"shares":49981,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":49981},"source":{"system":"sec-edgar","filing":"0001209191-20-006599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000120919120006599/doc4.xml","form_type":"4"}},{"id":3291611,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-04T23:26:31.000Z","date":"2020-02-04","kind":"exercise","acquired":false,"shares":37486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37486},"source":{"system":"sec-edgar","filing":"0001209191-20-006599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000120919120006599/doc4.xml","form_type":"4"}},{"id":3291610,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T23:26:31.000Z","date":"2020-02-04","kind":"exercise","acquired":true,"shares":49981,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":49981,"source":{"system":"sec-edgar","filing":"0001209191-20-006599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000120919120006599/doc4.xml","form_type":"4"}},{"id":3291609,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-04T23:26:31.000Z","date":"2020-02-04","kind":"exercise","acquired":true,"shares":37486,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":901391,"source":{"system":"sec-edgar","filing":"0001209191-20-006599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000120919120006599/doc4.xml","form_type":"4"}},{"id":3325428,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-03T10:50:30.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.415,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-000632","document":"tm201128d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000110465920000632/tm201128d2_4.xml","form_type":"4"}},{"id":3397657,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-10-04T18:01:31.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":12784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the fourth quarter of 2019."}],"balance_after":12784,"derivative":{"exercise_price":0.88,"exercise_date":"2020-10-02","expiration_date":"2029-10-02","underlying":"Common Stock","underlying_shares":12784},"source":{"system":"sec-edgar","filing":"0001144204-19-047421","document":"tv530701_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419047421/tv530701_form4.xml","form_type":"4"}},{"id":3469789,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-07-03T11:35:27.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":16346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the third quarter of 2019."}],"balance_after":16346,"derivative":{"exercise_price":0.65,"exercise_date":"2020-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":16346},"source":{"system":"sec-edgar","filing":"0001144204-19-033716","document":"tv524755_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419033716/tv524755_form4.xml","form_type":"4"}},{"id":3503660,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T14:41:20.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":10000,"price":0.7005,"value":7005.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6776 to $0.7300, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001144204-19-029688","document":"tv523061_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419029688/tv523061_form4.xml","form_type":"4"}},{"id":3526956,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-15T18:24:18.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":12355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the second quarter of 2019."}],"balance_after":12355,"derivative":{"exercise_price":0.86,"exercise_date":"2020-05-13","expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":12355},"source":{"system":"sec-edgar","filing":"0001144204-19-026692","document":"tv521753_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419026692/tv521753_form4.xml","form_type":"4"}},{"id":3526955,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-15T18:24:18.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":13081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the first quarter of 2019."}],"balance_after":13081,"derivative":{"exercise_price":0.86,"exercise_date":"2020-05-13","expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":13081},"source":{"system":"sec-edgar","filing":"0001144204-19-026692","document":"tv521753_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419026692/tv521753_form4.xml","form_type":"4"}},{"id":3706403,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-04T16:01:52.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.32,"exercise_date":"2020-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-19-000651","document":"tv510283_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419000651/tv510283_4.xml","form_type":"4"}},{"id":3750326,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.5,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":3750325,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.5,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":3750324,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":12.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.19,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":3750323,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":12.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.79,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":3750322,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":7920,"price":12.5,"value":99000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.141,"expiration_date":"2024-01-25","underlying":"Common Stock","underlying_shares":7920},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":3750321,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-29T00:50:31.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":34203,"price":12.5,"value":427537.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.222,"expiration_date":"2023-02-27","underlying":"Common Stock","underlying_shares":34203},"source":{"system":"sec-edgar","filing":"0001567619-18-007064","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000156761918007064/doc1.xml","form_type":"4"}},{"id":4109437,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-01-04T16:11:53.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":3.85,"exercise_date":"2019-01-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-000814","document":"tv482602_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418000814/tv482602_form4.xml","form_type":"4"}},{"id":4141915,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-12-06T00:34:28.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12th of the total number of shares on January 1, 2018 and then 1/12th monthly thereafter."}],"balance_after":15000,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-045101","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000114036117045101/doc1.xml","form_type":"4"}},{"id":4500453,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-01-05T16:08:28.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":7.05,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-000865","document":"v456320_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420417000865/v456320_form4.xml","form_type":"4"}},{"id":4511848,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":34849,"kind":"person","name":"CHAUDHURI BHASKAR","position":1,"cik":"0001458643","reported_name":"CHAUDHURI BHASKAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2016-12-27T23:09:31.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12th of the total number of shares on January 22, 2017 and then 1/12th monthly thereafter."}],"balance_after":15000,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-16-090840","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458643/000114036116090840/doc1.xml","form_type":"4"}}]}